The Multiple Sclerosis
Society (MS Society) is
asking researchers to
submit their novel
multiple sclerosis targets
MRC Technology and MS Society are working together to develop novel therapeutics for the treatment of MS.
The MS Society is providing £150k to researchers to fund the validation of promising novel drug targets. Upon completion, projects will be evaluated by MRC Technology for further development as small molecule or therapeutic antibody projects.
To submit your MS target please download an application form.
If you would like to chat with us before submitting a target please call the number above or send us an email.